Correlation Between Fate Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Fate Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for Fate Therapeutics and Milestone Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Fate and Milestone is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Milestone Pharmaceuticals
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Milestone Pharmaceuticals. In addition to that, Fate Therapeutics is 1.4 times more volatile than Milestone Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 396.00 in Milestone Pharmaceuticals on September 3, 2024 and sell it today you would lose (197.00) from holding Milestone Pharmaceuticals or give up 49.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fate Therapeutics vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Fate Therapeutics |
| Milestone Pharmaceuticals |
Fate Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fate Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite Fate Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Fate Therapeutics vs. DiaMedica Therapeutics | Fate Therapeutics vs. Lyra Therapeutics | Fate Therapeutics vs. Centessa Pharmaceuticals PLC |
| Milestone Pharmaceuticals vs. DiaMedica Therapeutics | Milestone Pharmaceuticals vs. Lyra Therapeutics | Milestone Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |